Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Ugeskrift for Laeger|March 29, 2003
[Molecular biology diagnostics: malignant lymphoid tumors in adults]Christian Bjørn Poulsen, Elisabeth Methner Ralfkiaer, Niels Borregaard, et al.Advances in Hematology|August 29, 2025
Real-World Safety and Efficacy of Venetoclax in Chronic Lymphocytic Leukemia: A Single-Center Comparative Analysis With Randomized Clinical TrialsSophie Thau, Christian Bjørn Poulsen, Morten Kranker Larsen, et al.European Journal of Haematology|November 8, 2007
Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroupsLene Dissing Sjö, Christian Bjørn Poulsen, Mads Hansen, et al.Blood|July 27, 2006
Prognostic significance of metallothionein in B-cell lymphomasChristian Bjørn Poulsen, Rehannah Borup, Niels Borregaard, et al.Annals of Hematology|April 18, 2024
COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort studySophie Thau, Christian Bjørn Poulsen, Christian Brieghel, et al.European Journal of Haematology|May 7, 2005
Microarray-based classification of diffuse large B-cell lymphomaChristian Bjørn Poulsen, Rehannah Borup, Finn Cilius Nielsen, et al.Journal of Neurochemistry|January 25, 2005
Brain response to traumatic brain injury in wild-type and interleukin-6 knockout mice: a microarray analysisChristian Bjørn Poulsen, Milena Penkowa, Rehannah Borup, et al.Hemasphere|July 17, 2025
Polypharmacy independently predicts survival, hospitalization, and infections in patients with lymphoid cancerChristian Brieghel, Thomas Lacoppidan, Esben Packness, et al.Journal of Neuroscience Research|August 31, 2006
Novel roles for metallothionein-I + II (MT-I + II) in defense responses, neurogenesis, and tissue restoration after traumatic brain injury: insights from global gene expression profiling in wild-type and MT-I + II knockout miceMilena Penkowa, Mario Cáceres, Rehannah Borup, et al.Pageof 5